Literature DB >> 19713529

MiR-128 up-regulation inhibits Reelin and DCX expression and reduces neuroblastoma cell motility and invasiveness.

Cristina Evangelisti1, Maria Carolina Florian, Isabella Massimi, Carlo Dominici, Giuseppe Giannini, Silvia Galardi, Maria Cristina Buè, Simone Massalini, Heather P McDowell, Elio Messi, Alberto Gulino, Maria Giulia Farace, Silvia Anna Ciafrè.   

Abstract

MicroRNAs are a class of sophisticated regulators of gene expression, acting as post-transcriptional inhibitors that recognize their target mRNAs through base pairing with short regions along the 3'UTRs. Several microRNAs are tissue specific, suggesting a specialized role in tissue differentiation or maintenance, and quite a few are critically involved in tumorigenesis. We studied miR-128, a brain-enriched microRNA, in retinoic acid-differentiated neuroblastoma cells, and we found that this microRNA is up-regulated in treated cells, where it down-modulates the expression of two proteins involved in the migratory potential of neural cells: Reelin and DCX. Consistently, miR-128 ectopic overexpression suppressed Reelin and DCX, whereas the LNA antisense-mediated miR-128 knockdown caused the two proteins to increase. Ectopic miR-128 overexpression reduced neuroblastoma cell motility and invasiveness, and impaired cell growth. Finally, the analysis of a small series of primary human neuroblastomas showed an association between high levels of miR-128 expression and favorable features, such as favorable Shimada category or very young age at diagnosis. Thus, we provide evidence for a role for miR-128 in the molecular events modulating neuroblastoma progression and aggressiveness.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19713529     DOI: 10.1096/fj.09-134965

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  71 in total

1.  A conserved microRNA/NMD regulatory circuit controls gene expression.

Authors:  Rachid Karam; Miles Wilkinson
Journal:  RNA Biol       Date:  2012-01-01       Impact factor: 4.652

2.  Direct regulation of the proglucagon gene by insulin, leptin, and cAMP in embryonic versus adult hypothalamic neurons.

Authors:  Prasad S Dalvi; Frederick D Erbiceanu; David M Irwin; Denise D Belsham
Journal:  Mol Endocrinol       Date:  2012-06-05

Review 3.  microRNAs: tiny RNA molecules, huge driving forces to move the cell.

Authors:  Shenglin Huang; Xianghuo He
Journal:  Protein Cell       Date:  2010-11-09       Impact factor: 14.870

4.  MicroRNA-128 downregulates Bax and induces apoptosis in human embryonic kidney cells.

Authors:  Yogita K Adlakha; Neeru Saini
Journal:  Cell Mol Life Sci       Date:  2010-09-19       Impact factor: 9.261

5.  MicroRNA cloning and sequencing in osteosarcoma cell lines: differential role of miR-93.

Authors:  Luisa Montanini; Lisa Lasagna; Valeria Barili; Søren Peter Jonstrup; Alba Murgia; Laura Pazzaglia; Amalia Conti; Chiara Novello; Jørgen Kjems; Roberto Perris; Maria Serena Benassi
Journal:  Cell Oncol (Dordr)       Date:  2011-09-30       Impact factor: 6.730

6.  Retinoic acid and microRNA.

Authors:  Lijun Wang; Atharva Piyush Rohatgi; Yu-Jui Yvonne Wan
Journal:  Methods Enzymol       Date:  2020-03-28       Impact factor: 1.600

7.  Tumour necrosis factor-α (TNF-α) and miRNA expression in frontal and temporal neocortex in Alzheimer's disease and the effect of TNF-α on miRNA expression in vitro.

Authors:  Doris Culpan; Patrick G Kehoe; Seth Love
Journal:  Int J Mol Epidemiol Genet       Date:  2011-03-25

Review 8.  MicroRNA: a connecting road between apoptosis and cholesterol metabolism.

Authors:  Yogita K Adlakha; Neeru Saini
Journal:  Tumour Biol       Date:  2016-04-22

9.  Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer.

Authors:  Amjad P Khan; Laila M Poisson; Vadiraja B Bhat; Damian Fermin; Rong Zhao; Shanker Kalyana-Sundaram; George Michailidis; Alexey I Nesvizhskii; Gilbert S Omenn; Arul M Chinnaiyan; Arun Sreekumar
Journal:  Mol Cell Proteomics       Date:  2009-11-09       Impact factor: 5.911

10.  MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2.

Authors:  Niamh H Foley; Isabella M Bray; Amanda Tivnan; Kenneth Bryan; Derek M Murphy; Patrick G Buckley; Jacqueline Ryan; Anne O'Meara; Maureen O'Sullivan; Raymond L Stallings
Journal:  Mol Cancer       Date:  2010-04-21       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.